Opportunities for genomic clinical decision support interventions. In Proceedings of the SIGCHI Conference on Human Factors in Computing Systems. Mayo Clin Proc Innov Qual Outcomes 2018 2 (02) 103-112įinding usability problems through heuristic evaluation. J Clin Lipidol 2016 10 (05) 1230-1239Ī clinical decision support tool for familial hypercholesterolemia based on physician input. Rapid identification of familial hypercholesterolemia from electronic health records: the SEARCH study. Lessening the burden of familial hypercholesterolemia using health information technology. Ann Intern Med 2016 165 (11) 753-760Īssociation of the usability of electronic health records with cognitive workload and performance levels among physicians. Circ Genom Precis Med 2019 12 (11) e002723Īllocation of physician time in ambulatory practice: a time and motion study in 4 specialties. New case detection by cascade testing in familial hypercholesterolemia: a systematic review of the literature. My approach to the patient with familial hypercholesterolemia. Use of Twitter to promote awareness of familial hypercholesterolemia.
Will precision medicine improve population health?. Tier 1 Genomics Applications and their Importance to Public Health | CDC. The lessons learned herein may be helpful in streamlining the development and deployment of CDS to facilitate genomic medicine implementation. During CDS implementation six main challenges were identified: (1) need for multiple institutional committee approvals (2) need to align the CDS with institutional knowledge resources (3) need to adapt the CDS to differing workflows (4) lack of institutional guidelines for CDS implementation (5) transition to a new institutional electronic health record (EHR) system and (6) limitations of the EHR related to genomic medicine.Ĭonclusion We identified multiple challenges in different domains while developing CDS for FH and integrating it with the EHR. The role of diet in the aetiopathogenesis of inflammatory bowel disease. During this 4-year period, we engaged with 15 stakeholder groups to build and integrate the CDS, including health care providers who gave feedback at each stage of development. Arterial Ultrasonography and Tonometry as Adjuncts to Cardiovascular Risk StratificationFree Access. Results The timeline for this work was approximately 4 years algorithm development and validation occurred from August 2018 to February 2020. Methods CDS development and implementation were conducted in four phases: (1) development and validation of an algorithm to identify “possible FH” (2) obtaining approvals from institutional committees to develop the CDS (3) development of the initial prototype and (4) use of an implementation science framework to evaluate the CDS. We describe our experience in the development and implementation of a genomic CDS for FH at a large academic medical center. Clinical decision support (CDS) tools have the potential to increase FH detection. Circulation 133, 1181–1188 (2016).Objective Familial hypercholesterolemia (FH), a prevalent genomic disorder that increases risk of coronary heart disease, remains significantly underdiagnosed. Incorporating a genetic risk score into coronary heart disease risk estimates: effect on low-density lipoprotein cholesterol levels (the MI-GENES clinical trial). Predictive utility of polygenic risk scores for coronary heart disease in three major racial and ethnic groups. Precision cardiovascular medicine: state of genetic testing. Ethical, legal, and social implications of incorporating genomic information into electronic health records. Establishment of specialized clinical cardiovascular genetics programs: recognizing the need and meeting standards: a scientific statement from the American Heart Association.
0 kommentar(er)
